COVID-19: Zydus Cadila seeks DCGI approval for clinical trials for monoclonal antibody therapy - Job Community
ads
Responsive Ads Here

Post Top Ad

Your Ad Spot

Thursday, 27 May 2021

Home Current Affairs Jagran Josh COVID-19: Zydus Cadila seeks DCGI approval for clinical trials for monoclonal antibody therapy

COVID-19: Zydus Cadila seeks DCGI approval for clinical trials for monoclonal antibody therapy

Zydus Cadila is the only Indian company that has been able to develop a neutralizing monoclonal antibody-based cocktail to neutralize COVID-19. Read what is monoclonal antibody therapy?



from Jagran Josh https://ift.tt/3vtNuwn
Tags
Posted by at
Labels: ,

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Post Top Ad

Your Ad Spot